Literature DB >> 25512797

Nonalcoholic steatohepatitis and insulin resistance in children.

Mikage Arata1, Junya Nakajima1, Shigeo Nishimata1, Tomomi Nagata1, Hisashi Kawashima1.   

Abstract

Various pathological conditions can cause fatty liver in children. Nonalcoholic steatohepatitis (NASH) in children has been known since 1983. However, NASH diagnosed in childhood does not have a favorable outcome. The pathological characteristics of NASH are significantly different between children and adults. Nonalcoholic fatty liver disease (NAFLD)/NASH is accompanied by insulin resistance, which plays a pivotal role in its pathophysiology in both children and adults. In NASH, a "two-hit" model involving triglyceride accumulation (first hit) and liver damage (second hit) has been accepted. Insulin resistance was found to correlate with changes in fat levels; however, it did not correlate with fibrosis or NAFLD activity score in children. Therefore, insulin resistance may be important in the first hit. Because there is obvious familial clustering in NASH, genetic predisposition as well as environmental factors including diet might be the second hit of NAFLD/NASH.

Entities:  

Keywords:  Homeostasis model assessment as an index of insulin resistance; Insulin resistance; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Obesity

Year:  2014        PMID: 25512797      PMCID: PMC4265881          DOI: 10.4239/wjd.v5.i6.917

Source DB:  PubMed          Journal:  World J Diabetes        ISSN: 1948-9358


  47 in total

1.  Relationship between adipose tissue insulin resistance and liver histology in nonalcoholic steatohepatitis: a pioglitazone versus vitamin E versus placebo for the treatment of nondiabetic patients with nonalcoholic steatohepatitis trial follow-up study.

Authors:  Lauren N Bell; Jiangxia Wang; Sriya Muralidharan; Sadhana Chalasani; Allison M Fullenkamp; Laura A Wilson; Arun J Sanyal; Kris V Kowdley; Brent A Neuschwander-Tetri; Elizabeth M Brunt; Arthur J McCullough; Nathan M Bass; Anna Mae Diehl; Aynur Unalp-Arida; Naga Chalasani
Journal:  Hepatology       Date:  2012-08-21       Impact factor: 17.425

2.  Contribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease.

Authors:  Shinji Tamura; Iichiro Shimomura
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

3.  Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease.

Authors:  Kerry L Donnelly; Coleman I Smith; Sarah J Schwarzenberg; Jose Jessurun; Mark D Boldt; Elizabeth J Parks
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

4.  Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease.

Authors:  Heather M Patton; Katherine Yates; Aynur Unalp-Arida; Cynthia A Behling; Terry T-K Huang; Philip Rosenthal; Arun J Sanyal; Jeffrey B Schwimmer; Joel E Lavine
Journal:  Am J Gastroenterol       Date:  2010-04-06       Impact factor: 10.864

5.  Hepatic progenitor cells activation, fibrosis, and adipokines production in pediatric nonalcoholic fatty liver disease.

Authors:  Valerio Nobili; Guido Carpino; Anna Alisi; Antonio Franchitto; Gianfranco Alpini; Rita De Vito; Paolo Onori; Domenico Alvaro; Eugenio Gaudio
Journal:  Hepatology       Date:  2012-12       Impact factor: 17.425

6.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

Authors:  E M Brunt; C G Janney; A M Di Bisceglie; B A Neuschwander-Tetri; B R Bacon
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

7.  Steatohepatitis in obese children: a cause of chronic liver dysfunction.

Authors:  J R Moran; F K Ghishan; S A Halter; H L Greene
Journal:  Am J Gastroenterol       Date:  1983-06       Impact factor: 10.864

8.  Obesity in adulthood and its consequences for life expectancy: a life-table analysis.

Authors:  Anna Peeters; Jan J Barendregt; Frans Willekens; Johan P Mackenbach; Abdullah Al Mamun; Luc Bonneux
Journal:  Ann Intern Med       Date:  2003-01-07       Impact factor: 25.391

9.  The association between hepatic fat content and liver injury in obese children and adolescents: effects of ethnicity, insulin resistance, and common gene variants.

Authors:  Nicola Santoro; Ariel E Feldstein; Erik Enoksson; Bridget Pierpont; Romy Kursawe; Grace Kim; Sonia Caprio
Journal:  Diabetes Care       Date:  2012-12-28       Impact factor: 19.112

10.  Genetic polymorphisms in non-alcoholic fatty liver disease in obese Egyptian children.

Authors:  Nehal M El-Koofy; Hanaa M El-Karaksy; Iman M Mandour; Ghada M Anwar; Mona S El-Raziky; Ahmad M El-Hennawy
Journal:  Saudi J Gastroenterol       Date:  2011 Jul-Aug       Impact factor: 2.485

View more
  8 in total

1.  Purinergic receptor X7 mediates leptin induced GLUT4 function in stellate cells in nonalcoholic steatohepatitis.

Authors:  Varun Chandrashekaran; Suvarthi Das; Ratanesh Kumar Seth; Diptadip Dattaroy; Firas Alhasson; Gregory Michelotti; Mitzi Nagarkatti; Prakash Nagarkatti; Anna Mae Diehl; Saurabh Chatterjee
Journal:  Biochim Biophys Acta       Date:  2015-10-22

2.  Plasma cathepsin D correlates with histological classifications of fatty liver disease in adults and responds to intervention.

Authors:  Sofie M A Walenbergh; Tom Houben; Sander S Rensen; Veerle Bieghs; Tim Hendrikx; Patrick J van Gorp; Yvonne Oligschlaeger; Mike L J Jeurissen; Marion J J Gijbels; Wim A Buurman; Anita C E Vreugdenhil; Jan Willem M Greve; Jogchum Plat; Marten H Hofker; Satish Kalhan; Jussi Pihlajamäki; Patrick Lindsey; Ger H Koek; Ronit Shiri-Sverdlov
Journal:  Sci Rep       Date:  2016-12-06       Impact factor: 4.379

3.  Gut microbiota-mediated generation of saturated fatty acids elicits inflammation in the liver in murine high-fat diet-induced steatohepatitis.

Authors:  Shoji Yamada; Nobuhiko Kamada; Takeru Amiya; Nobuhiro Nakamoto; Toshiaki Nakaoka; Masaki Kimura; Yoshimasa Saito; Chieko Ejima; Takanori Kanai; Hidetsugu Saito
Journal:  BMC Gastroenterol       Date:  2017-11-29       Impact factor: 3.067

4.  Pathologic Impact of Insulin Resistance and Sensitivity on the Severity of Liver Histopathology in Pediatric Non-Alcoholic Steatohepatitis.

Authors:  Byung Han Park; Jung Min Yoon; Ja Hye Kim; Jin Hwa Moon; Young Ho Lee; Se Min Jang; Yong Joo Kim
Journal:  Yonsei Med J       Date:  2017-07       Impact factor: 2.759

5.  Bile acid metabolism regulated by the gut microbiota promotes non-alcoholic steatohepatitis-associated hepatocellular carcinoma in mice.

Authors:  Shoji Yamada; Yoko Takashina; Mitsuhiro Watanabe; Ryogo Nagamine; Yoshimasa Saito; Nobuhiko Kamada; Hidetsugu Saito
Journal:  Oncotarget       Date:  2018-01-06

Review 6.  Mechanism and Therapeutic Targets of c-Jun-N-Terminal Kinases Activation in Nonalcoholic Fatty Liver Disease.

Authors:  Robert W M Min; Filbert W M Aung; Bryant Liu; Aliza Arya; Sanda Win
Journal:  Biomedicines       Date:  2022-08-20

7.  Prospective assessment of liver stiffness by shear wave elastography in childhood obesity: a pilot study.

Authors:  Domenico Corica; Antonio Bottari; Tommaso Aversa; Letteria Anna Morabito; Selenia Curatola; Angela Alibrandi; Giorgio Ascenti; Malgorzata Wasniewska
Journal:  Endocrine       Date:  2021-07-23       Impact factor: 3.633

8.  Nrf2-mediated anti-oxidant effects contribute to suppression of non-alcoholic steatohepatitis-associated hepatocellular carcinoma in murine model.

Authors:  Shoji Yamada; Masaki Kimura; Yoshimasa Saito; Hidetsugu Saito
Journal:  J Clin Biochem Nutr       Date:  2018-04-03       Impact factor: 3.114

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.